SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025995
Filing Date
2022-12-02
Accepted
2022-12-02 16:08:14
Documents
14
Period of Report
2022-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20221202.htm   iXBRL 8-K 66879
2 EX-99.1 nktx-ex99_1.htm EX-99.1 12826
3 GRAPHIC img220989892_0.jpg GRAPHIC 4515
  Complete submission text file 0000950170-22-025995.txt   216004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20221202_lab.xml EX-101.LAB 18527
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20221202_pre.xml EX-101.PRE 11494
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20221202.xsd EX-101.SCH 2462
8 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20221202_htm.xml XML 4887
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 221442006
SIC: 2834 Pharmaceutical Preparations